# FDA Inspection 1162509 - George A. Diaz, M.D., Ph.D. - January 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/george-a-diaz-md-phd/001e489c-b4c9-4f8b-b26c-25273691e5f3
Source feed: FDA_Inspections

> FDA Inspection 1162509 for George A. Diaz, M.D., Ph.D. on January 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162509
- Company Name: George A. Diaz, M.D., Ph.D.
- Inspection Date: 2022-01-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 785838 - 2012-05-09](https://www.keypedia.com/records/fda_inspections/george-a-diaz-md-phd/689ba4bf-e38e-4dfc-8428-c6bb1ceb5dce)

Company: https://www.keypedia.com/companies/george-a-diaz-md-phd/46cde4a9-ad99-448a-87b0-b1628913e80d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c